Hamilton’s Pharmacopeia – Ketamine – Season 2 Episode 5
Hamilton Morris spent 3 days with Dr. Raquel Bennett (founder of KRIYA Institute) talking about therapeutic ketamine. Filmed in Hillsborough, CA in July 2017.
Hamilton Morris spent 3 days with Dr. Raquel Bennett (founder of KRIYA Institute) talking about therapeutic ketamine. Filmed in Hillsborough, CA in July 2017.
Can LSD and psilocybin provide relief to people suffering from difficult-to-treat conditions such as depression and anxiety? Robin Carhart-Harris is a neuroscientist and head of the Imperial Centre for Psychedelic Research, which builds on over a decade of pioneering work psychedelic research, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression.
Can LSD and psilocybin provide relief to people suffering from difficult-to-treat conditions such as depression and anxiety? Robin Carhart-Harris is a neuroscientist and head of the Imperial Centre for Psychedelic Research, which builds on over a decade of pioneering work psychedelic research, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression.
The powerful effects that ketamine has on the brain’s neurons have led doctors to further explore its medical potential, and now, ketamine infusion therapy and ketamine nasal sprays are giving those with severe depression new hope.
Rhonda Patrick explains what NAD+, why it is so important for aging and why it declines with age. She discusses some of the popular NAD+ boosters like nicotinamide riboside and nicotinamide mononucleotide, what animal and human data says and some concluding thoughts.
Petter Attia MD in conversation with David Sinclair PhD about aging, longevity, NAD and more.
Rhonda Patrick explains what NAD+, why it is so important for aging and why it declines with age. She discusses some of the popular NAD+ boosters like nicotinamide riboside and nicotinamide mononucleotide, what animal and human data says and some concluding thoughts.
Dr. Jennifer Vande Voort, a Mayo Clinic psychiatrist, discusses esketamine nasal spray — a fast-acting treatment for depression that recently was approved by the Food and Drug Administration.
Dr. Sanjay Gupta shares the story of Alan Ferguson, who is being treated with ketamine, a powerful anesthetic medication used in hospitals, for severe depression.
Sean Spencer is a pretty successful entrepreneur in LA’s startup community but he also struggles with depression, so he uses ketamine to help with his lows.